**Core Concept**
Pemphigus vulgaris is a chronic autoimmune skin disease characterized by the formation of blisters on the skin and mucous membranes, resulting from the production of autoantibodies against desmoglein 3, a component of the epidermal cadherin complex. This leads to the disruption of intercellular connections between keratinocytes, causing acantholysis and blister formation.

**Why the Correct Answer is Right**
Direct immunofluorescence (DIF) is the most useful test for confirming Pemphigus vulgaris. DIF involves the application of fluorescent antibodies against human IgG or complement components to a skin biopsy specimen. In Pemphigus vulgaris, DIF typically shows intercellular staining of IgG antibodies along the basement membrane zone, indicating the presence of autoantibodies against desmoglein 3. This is a hallmark finding of the disease and is essential for diagnosis.

**Why Each Wrong Option is Incorrect**
**Option A:** Indirect immunofluorescence (IIF) is less specific for Pemphigus vulgaris and can show a variety of patterns, including the presence of circulating autoantibodies against desmoglein 3. However, IIF is not as sensitive as DIF for detecting intercellular antibodies.
**Option B:** Enzyme-linked immunosorbent assay (ELISA) can detect circulating autoantibodies against desmoglein 3, but it is not specific for Pemphigus vulgaris and can be negative in some cases.
**Option C:** Complement-dependent cytotoxicity (CDC) assay is not typically used for diagnosing Pemphigus vulgaris and is more relevant to other autoimmune diseases.

**Clinical Pearl / High-Yield Fact**
The presence of autoantibodies against desmoglein 3 is a hallmark of Pemphigus vulgaris, and direct immunofluorescence is the most useful test for confirming the diagnosis. DIF can help differentiate Pemphigus vulgaris from other autoimmune bullous diseases, such as Pemphigoid.

**Correct Answer: C. Complement-dependent cytotoxicity (CDC) assay is not typically used for diagnosing Pemphigus vulgaris and is more relevant to other autoimmune diseases.**